Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02718352 · ClinicalTrials.gov registry record
A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 8
- Enrollment target
NCT02718352: Completed study, sponsored by Yale University.
NCT02718352 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02718352 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Many buprenorphine treatment programs do not have services dedicated to adolescents and young adults. As a precursor to developing and evaluating an adolescent and young adult buprenorphine treatment program at APT Foundation Inc, we propose to conduct a 1 year prospective study of 16 to 25 year old treatment-seeking individuals enrolled in the APT Adolescent and Young Adult Suboxone Program
Primary Outcome
To describe the progression of opioid use among adolescents and young adults participating in buprenorphine treatment, the subjects will fill out time line follow back surveys to describe opioid use patterns.
Interventions
- OTHER Naturalistic Prospective Cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-03 |
What the finished NCT02718352 record still lists
NCT02718352 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Naturalistic Prospective Cohort is the first listed.
NCT02718352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02718352 about?
NCT02718352 is a clinical study titled "A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence". Many buprenorphine treatment programs do not have services dedicated to adolescents and young adults. As a precursor to developing and evaluating an adolescent and young adult buprenorphine treatment program at APT Foundation Inc, we propose to conduct a 1 year prospective study of 16 to 25 year old...
What is the current status of trial NCT02718352?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2016-03. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02718352?
The interventions under investigation include: Naturalistic Prospective Cohort (OTHER).
Who is sponsoring clinical trial NCT02718352?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia